Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease.
about
Parkinson's disease: from monogenic forms to genetic susceptibility factorsGenetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation updateLRRK2 kinase activity and biology are not uniformly predicted by its autophosphorylation and cellular phosphorylation site statusLRRK2 phosphorylates novel tau epitopes and promotes tauopathyHeterogeneity of leucine-rich repeat kinase 2 mutations: genetics, mechanisms and therapeutic implicationsGenetics of Parkinson's disease - a clinical perspectiveProgressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in miceGenetics in Parkinson disease: Mendelian versus non-Mendelian inheritanceExploring the Effects of Genetic Variants on Clinical Profiles of Parkinson's Disease Assessed by the Unified Parkinson's Disease Rating Scale and the Hoehn-Yahr StageLRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors.Common variation in the LRRK2 gene is a risk factor for Parkinson's disease.LRRK2 A419V is not associated with Parkinson's disease in different Chinese populations.LRRK2 mutations and risk variants in Japanese patients with Parkinson's diseaseMechanisms of Parkinson's disease-related proteins in mediating secondary brain damage after cerebral ischemia.LINGO1 rs9652490 is associated with essential tremor and Parkinson diseaseLeucine-rich repeat kinase 2 gene-associated disease: redefining genotype-phenotype correlationLeucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson's diseaseFGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression.Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus.LRRK2 variation and Parkinson's disease in African Americans.Genetic variability at the PARK16 locusLRRK2 G2385R and R1628P mutations are associated with an increased risk of Parkinson's disease in the Malaysian population.The genetic background of Parkinson's disease: current progress and future prospects.Association between GRN rs5848 polymorphism and Parkinson's disease in Taiwanese populationThe genetics of Parkinson disease.Patterns of linkage disequilibrium of LRRK2 across different races: implications for genetic association studies.Lrrk2 R1628P variant is a risk factor for essential tremorLrrk2 p.Q1111H substitution and Parkinson's disease in Latin America.Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.LRRK2 and ubiquitination: implications for kinase inhibitor therapyDifferential effect of caffeine intake in subjects with genetic susceptibility to Parkinson's Disease.The genetics of Parkinson's disease: progress and therapeutic implicationsDopamine beta-hydroxylase -1021C>T association and Parkinson's disease.Clinical and genetic description of a family with a high prevalence of autosomal dominant restless legs syndrome.Phactr2 and Parkinson's disease.Analysis of LRRK2, SNCA, and ITGA8 Gene Variants with Sporadic Parkinson's Disease Susceptibility in Chinese Han Population.Loss of leucine-rich repeat kinase 2 (LRRK2) in rats leads to progressive abnormal phenotypes in peripheral organsProtective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's disease.Emerging pathways in genetic Parkinson's disease: tangles, Lewy bodies and LRRK2.
P2860
Q22242870-E296A45F-4EAF-4FA0-8071-C13C5A3E8D9CQ22252904-8CCA7C7C-23D0-4BCD-9A40-07221CF445A6Q24300605-E9B2EF3D-C3BB-4641-85B1-7547133AC20BQ24338188-37AB0949-B0E2-40F8-81AA-304D5D0110A5Q27013695-3CCB12D6-0F24-4049-8E82-A34927E46B52Q27022109-A8B6D806-89DB-4238-8F34-2DE324610B16Q27308060-835A4A59-5FD1-41FE-83FF-9516B55A7175Q28077356-4661BE79-6982-43E6-BB1A-631C030C7584Q28396892-012BAA77-E303-430B-945B-0CE78C361DDDQ30524899-638467CA-9622-4642-A74F-F6B888EE3787Q30531323-0DF050C7-DBF9-44E8-8493-FB3594CEDAA4Q31074483-6258EAA0-9762-4AA3-A836-39F28360E6A2Q33682480-C4DCB15B-285B-428B-A0FE-57B1CA7C9FE8Q33727623-4597B726-F253-4C41-B5F1-7DC09044ABA1Q33747837-FC1AA590-384B-445B-9361-4147246A434FQ33808789-851431B9-E68B-47F6-82C8-63AEE18B63B9Q33812599-0FD39E3F-F5C6-43BA-BD73-A8784C79FC90Q33873286-337E9BAF-067E-47CA-98E2-6FB1A31AC9E1Q34053286-C75EBD09-415C-4BD0-B3B8-78A3EA2A5166Q34126355-BCF0AE07-BC01-451A-B09A-7A2D9090F467Q34129582-0751731C-CB2B-4921-B120-ADA3889653D7Q34177234-A69B825F-38A3-4D85-BB4F-6069B2ED4EEDQ34513714-774F270E-A79F-4E2C-A47C-A7028AE9CF8CQ34559477-6660C8DE-4BDB-4BAC-A7CF-7A7ECC1F248FQ34604083-E952E43D-CF41-4A83-A1A5-14955C8EDCBAQ34990504-18C69F0D-4216-4A31-88BF-67106E20E55CQ35169497-0992A22D-A136-45E6-A36F-48501A19B09FQ35199232-22411FAF-FC99-45D8-885B-DE4F209C1582Q35525896-0753F8C6-4234-4A38-82FB-C1425D163CCBQ36185165-BABD4A00-2293-48C4-A3CB-6914D7E8B0AEQ36237695-1E46B0CB-5729-4833-9BBB-7010843D8C8DQ36626825-6E4EC634-10A2-4C1C-841A-0F37B65150EBQ36992712-6B5CEDB4-9D2D-46E2-B289-4E0D1A1FB0A8Q37148359-C1B9C2A8-C4AC-437B-880F-26D57B089F74Q37198961-AF016853-4D7F-4A56-A057-A266A2A8034FQ37271108-65158579-0148-49ED-AA99-780178675820Q37308940-C8AB9E91-0524-45AD-82D4-20B438C3BD08Q37312762-DBAD1682-3480-485A-83BB-24912365F659Q37313530-95BBC86B-593A-4A28-B61A-B8D146FAD7ECQ37330540-003A536A-9085-4509-A26E-C298B90453B4
P2860
Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease.
@en
type
label
Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease.
@en
prefLabel
Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease.
@en
P2093
P50
P356
P1433
P1476
Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease.
@en
P2093
Alexandra I Soto
Chiung Mei Chen
Guey-Jen Lee-Chen
Mei-Ching Lee
Michelle Tang
P356
10.1002/ANA.21405
P50
P577
2008-07-01T00:00:00Z